Abstracts

Notifications on all submitted abstracts were sent out January 30. If you have any questions regarding your submission please contact info@clinimmsoc.org.

Late-Breaking Abstract Information

SUBMISSION INFORMATION

The purpose of the Late Breaking submission of abstracts is to give submitters/those attending the CIS meeting, the opportunity to report recently generated, meaningful and novel research on important immune deficiency and dysregulatory diseases in a timely way, and to advance our understanding of the molecular pathogenesis of these defects.

This is NOT an opportunity for those who have not been able to submit regular abstracts by the original deadline to submit those abstracts now.

GUIDELINES FOR LATE-BREAKING ABSTRACT SUBMISSIONS

Please follow the guidelines below when determining if you have an abstract worth submitting as part of the late-breaking abstract process:

• Research previously presented or published will not be accepted.
• All abstracts must be submitted online, via the CIS abstract submission portal.
• You do not need to be a member of CIS to submit an abstract.
• Submissions must be no longer than 350 words.
• Case Reports are not generally encouraged for submission as late-breaking abstracts unless they significantly advance the field of clinical immunology.
• All listed authors must complete a disclosure form.
• As part of the submission process, all submitters will be asked to list keywords that are relevant to the submission. Each submission is required to include three (3) keywords. Additional keywords, up to 10, may be included with the submission.

Beyond the requirements listed above there is no required format for how submissions must be written.

Questions about late-breaking abstract submission should be sent to info@clinimmsoc.org